Hyperglycemia leads to higher OGT substrate production (UDP-GlcNAc) in cells [41], and such elevated glucose to UDP-GlcNAc flux may outcompete the active site OGT inhibitor OSMI-4 in TNBC cells. The gene discussed is OGT; the disease is Hyperglycemia.